![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Boceprevir Plus Peginterferon/Ribavirin
for the Treatment of HCV/HIV Co-Infected Patients
|
|
|
Reported by Jules Levin IDSA Boston, MA Oct 22 2011
M Sulkowski1, S Pol2, C Cooper3, H Fainboim4, J Slim5, A Rivero6, S Thompson7, W Greaves7, J Wahl7, J Mallolas8
1John Hopkins University School of Medicine, Baltimore, MD; 2Hopital Cochin, Paris, France; 3The Ottawa Hospital, Ottawa, ON, Canada; 4F. J. Muniz Hospital De Infecciosas, Buenos Aires, Argentina; 5Saint Michael's Medical Center, Newark, NJ; 6Hospital Universitario Reina Sofia, Cordoba, Spain; 7Merck Sharp & Dohme, Whitehouse Station, NJ; 8Hospital Clinic i Provincial Barcelona, Spain
Late Breaker Oral Abstract LB-37
Infectious Diseases Society of America (IDSA) 49th Annual Meeting
Boston MA
October 22nd, 2011
![IDSA1.gif](../images/102311/102311-3/IDSA1.gif)
![IDSA2.gif](../images/102311/102311-3/IDSA2.gif)
![IDSA3.gif](../images/102311/102311-3/IDSA3.gif)
![IDSA4.gif](../images/102311/102311-3/IDSA4.gif)
![IDSA5.gif](../images/102311/102311-3/IDSA5.gif)
![IDSA6.gif](../images/102311/102311-3/IDSA6.gif)
![IDSA7.gif](../images/102311/102311-3/IDSA7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|